Compare TUYA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TUYA | ABCL |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2021 | 2020 |
| Metric | TUYA | ABCL |
|---|---|---|
| Price | $2.06 | $3.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.49 | ★ $7.75 |
| AVG Volume (30 Days) | 1.2M | ★ 4.9M |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | ★ 5.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $319,363,000.00 | $35,325,000.00 |
| Revenue This Year | $8.84 | $25.45 |
| Revenue Next Year | $12.17 | $10.07 |
| P/E Ratio | $27.19 | ★ N/A |
| Revenue Growth | ★ 13.66 | 7.17 |
| 52 Week Low | $1.87 | $1.89 |
| 52 Week High | $4.63 | $6.52 |
| Indicator | TUYA | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 37.33 |
| Support Level | $2.04 | $3.92 |
| Resistance Level | $2.22 | $4.25 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 11.45 | 4.51 |
Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.